Literature DB >> 31372708

Oral vitamin D3 supplementation increases serum fibroblast growth factor 23 concentration in vitamin D-deficient patients: a systematic review and meta-analysis.

N Charoenngam1,2, P Rujirachun3, M F Holick4, P Ungprasert5.   

Abstract

Studies have suggested that vitamin D supplementation may increase serum fibroblast growth factor 23 (FGF23) among vitamin D-deficient patients although the results were inconsistent across the studies. This systematic review and meta-analysis was conducted to summarize all available data. A systematic review was conducted using MEDLINE and EMBASE database from inception to February 2019 to identify studies that provided oral vitamin D3 supplement to vitamin D-deficient participants (25-hydroxyvitamin D < 20 ng/mL). Mean serum FGF23 concentration and standard deviation of participants at baseline and after vitamin D3 supplementation were extracted to calculate standard mean difference (SMD). Pooled SMD was calculated by combining SMDs of each study using random effects model. Nine studies were eligible for the meta-analyses. Seven studies measured serum intact FGF23, and two studies measured serum C-terminal FGF23. The meta-analyses found that serum intact FGF23 increased significantly after oral vitamin D3 supplementation in vitamin D-deficient participants with the pooled SMD of 0.36 (95%CI, 0.14, 0.57; p = 0.001; I2 of 36%). Serum C-terminal FGF23 also increased after vitamin D3 supplementation in vitamin D-deficient participants with the pooled SMD of 0.28 although without reaching statistical significance (95%CI, - 0.08, 0.65; p = 0.13; I2 of 0%). Funnel plot of the meta-analysis of serum intact FGF23 did not provide a suggestive evidence for publication bias. Vitamin D supplementation leads to a significant increase in serum intact FGF23 among vitamin D-deficient patients. An increase in serum C-terminal FGF23 was also observed although the number of included studies was too small to demonstrate statistical significance. The present systematic review and meta-analysis revealed that serum intact FGF23 concentration increased significantly after oral vitamin D3 supplementation in vitamin D-deficient participants. An increase in serum C-terminal FGF23 concentration was also observed although the number of included studies was too small to demonstrate statistical significance.

Entities:  

Keywords:  Fibroblast growth factor 23; Meta-analysis; Vitamin D deficiency; Vitamin D3 supplementation

Mesh:

Substances:

Year:  2019        PMID: 31372708     DOI: 10.1007/s00198-019-05102-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  28 in total

1.  Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23.

Authors:  Sherri-Ann M Burnett-Bowie; Benjamin Z Leder; Maria P Henao; Chantel M Baldwin; Douglas L Hayden; Joel S Finkelstein
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 8.237

2.  Effect of Cholecalciferol therapy on serum FGF23 in vitamin D deficient patients: a randomized clinical trial.

Authors:  T Kamelian; F Saki; M Jeddi; M H Dabbaghmanesh; G H R Omrani
Journal:  J Endocrinol Invest       Date:  2017-08-09       Impact factor: 4.256

3.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Authors:  Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

4.  Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

Authors:  Shiguang Liu; Wen Tang; Jianping Zhou; Jason R Stubbs; Qiang Luo; Min Pi; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2006-04-05       Impact factor: 10.121

5.  Effects of Cholecalciferol Supplementation in Patients with stable heart failure and LOw vITamin D levels (ECSPLOIT-D): a double-blind, randomized, placebo-controlled pilot study.

Authors:  Fabrizio Turrini; Stefania Scarlini; Paolo Giovanardi; Roberto Messora; Laura Roli; Johanna Chester; Chiara Mussi; Marco Bertolotti; Tommaso Trenti; Marco Bondi
Journal:  Minerva Cardioangiol       Date:  2017-05-31       Impact factor: 1.347

6.  Cholecalciferol supplementation in chronic kidney disease: restoration of vitamin D status and impact on parathyroid hormone.

Authors:  Miriam G Garcia-Lopes; Roberta Pillar; Maria Ayako Kamimura; Lillian A Rocha; Maria Eugênia F Canziani; Aluízio B Carvalho; Lilian Cuppari
Journal:  Ann Nutr Metab       Date:  2012-08-07       Impact factor: 3.374

Review 7.  FGF23 production by osteocytes.

Authors:  Lynda F Bonewald; Michael J Wacker
Journal:  Pediatr Nephrol       Date:  2012-09-16       Impact factor: 3.714

Review 8.  X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.

Authors:  Yuka Kinoshita; Seiji Fukumoto
Journal:  Endocr Rev       Date:  2018-06-01       Impact factor: 19.871

9.  A Randomized Study to Compare a Monthly to a Daily Administration of Vitamin D₃ Supplementation.

Authors:  Sophie De Niet; Monte Coffiner; Stéphanie Da Silva; Bernard Jandrain; Jean-Claude Souberbielle; Etienne Cavalier
Journal:  Nutrients       Date:  2018-05-23       Impact factor: 5.717

Review 10.  Physiological Actions of Fibroblast Growth Factor-23.

Authors:  Reinhold G Erben
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-28       Impact factor: 5.555

View more
  9 in total

Review 1.  Shedding Light on the Complex Regulation of FGF23.

Authors:  Marc G Vervloet
Journal:  Metabolites       Date:  2022-04-28

2.  Incidence rate of vitamin D deficiency and FGF23 levels in 12- to 13-year-old adolescents in Japan.

Authors:  Satomi Koyama; Takuo Kubota; Junko Naganuma; Osamu Arisaka; Keiichi Ozono; Shigemi Yoshihara
Journal:  J Bone Miner Metab       Date:  2020-11-18       Impact factor: 2.626

Review 3.  FGF23 and Phosphate-Cardiovascular Toxins in CKD.

Authors:  Isabel Vogt; Dieter Haffner; Maren Leifheit-Nestler
Journal:  Toxins (Basel)       Date:  2019-11-06       Impact factor: 4.546

4.  Is It Important to Increase Physical Activity Among University Students During the Second-Wave COVID-19 Pandemic in Asian Countries? A Cross-Sectional Study of the Knowledge, Attitudes, and Practices in Asian Countries.

Authors:  Dina Keumala Sari; Suresh Mani; Muhammad Fadli; Riyadh Ihksan; Yetty Machrina; Nurfida Khairina Arrasyid; Kamal Basri Siregar; Agung Sunarno
Journal:  J Multidiscip Healthc       Date:  2022-07-21

5.  Vitamin D3 Repletion Improves Vascular Function, as Measured by Cardiorenal Biomarkers in a High-Risk African American Cohort.

Authors:  Satyesh K Sinha; Ling Sun; Michelle Didero; David Martins; Keith C Norris; Jae Eun Lee; Yuan-Xiang Meng; Jung Hye Sung; Michael Sayre; Maria Beatriz Carpio; Susanne B Nicholas
Journal:  Nutrients       Date:  2022-08-14       Impact factor: 6.706

Review 6.  An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases.

Authors:  Claudia Sîrbe; Simona Rednic; Alina Grama; Tudor Lucian Pop
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

Review 7.  Immunologic Effects of Vitamin D on Human Health and Disease.

Authors:  Nipith Charoenngam; Michael F Holick
Journal:  Nutrients       Date:  2020-07-15       Impact factor: 5.717

Review 8.  Klotho, Aging, and the Failing Kidney.

Authors:  Sarah Buchanan; Emilie Combet; Peter Stenvinkel; Paul G Shiels
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-27       Impact factor: 5.555

9.  Phosphate and fibroblast growth factor 23 in diabetes.

Authors:  Amarens van der Vaart; Stanley M H Yeung; Peter R van Dijk; Stephan J L Bakker; Martin H de Borst
Journal:  Clin Sci (Lond)       Date:  2021-07-30       Impact factor: 6.124

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.